Amanote Research

Amanote Research

    RegisterSign In

Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient With a Cortisol-Secreting Adrenal Adenoma

Case Reports in Endocrinology - United States
doi 10.1155/2017/6161348
Full Text
Open PDF
Abstract

Available in full text

Categories
EndocrinologyMetabolismDiabetes
Date

January 1, 2017

Authors
Enzo RagucciDat NguyenMichele LamersonAndreas G. Moraitis
Publisher

Hindawi Limited


Related search

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

Nonalcoholic Fatty Liver Disease: A Pathological View

2012English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Nonalcoholic Fatty Liver Disease in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Nonalcoholic Fatty Liver Disease in 2020

Gastroenterology
HepatologyGastroenterology
2020English

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis

Journal of Clinical and Experimental Hepatology
Hepatology
2015English

In Brief: Nonalcoholic Fatty Liver Disease

Pediatrics in Review
MedicineChild HealthPediatricsPerinatology
2010English

Dehydroepiandrosterone in Nonalcoholic Fatty Liver Disease

2012English

Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy